← Back to Search

Advanced Care Planning for Sarcoma

N/A

Waitlist Available

Led By Megan Shen

Research Sponsored by Fred Hutchinson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, up to 4 weeks

Awards & highlights

Study Summary

This trial tests a checklist tool to assess future mobility needs for sarcoma patients. It may help improve quality of life by helping them plan for their future needs.

Who is the study for?

This trial is for English-speaking adults over 18 with sarcoma who've had limb surgery or are in active treatment for stage IV sarcoma. They must be able to consent and have computer access. Caregivers meeting the same criteria can also participate.Check my eligibility

What is being tested?

The study evaluates a checklist tool designed to assess future mobility needs of sarcoma patients post-surgery or during stage IV treatment, aiming to improve their quality of life by aiding in planning for mobility challenges.See study design

What are the potential side effects?

Since this trial involves assessments through questionnaires and interviews rather than medical treatments, there are no direct physical side effects associated with participating.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ after completion of intervention (+ 1 week)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~after completion of intervention (+ 1 week)

This trial's timeline: 3 weeks for screening, Varies for treatment, and after completion of intervention (+ 1 week) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of the intervention: Acceptability E-Scale

Acceptability: Satisfaction with the intervention

Feasibility, as measured by the number of subjects accrued to the study

+2 more

Secondary outcome measures

Change in completion of advance directives

Change in discussion of advance directives

Change in functional status

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive Care (advanced care planning checklist)Experimental Treatment4 Interventions

FIELD TEST: Participants complete the Advance Care Planning (ACP) Mobility Checklist on study. Participants complete questionnaires at baseline and after completing the checklist intervention and undergo interview on study. Participants medical records are also reviewed.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Assessment

2007

N/A

~2190

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Fred Hutchinson Cancer CenterLead Sponsor

556 Previous Clinical Trials

1,343,248 Total Patients Enrolled

18 Trials studying Sarcoma

1,260 Patients Enrolled for Sarcoma

Megan ShenPrincipal InvestigatorFred Hutch/University of Washington Cancer Consortium

1 Previous Clinical Trials

40 Total Patients Enrolled

Media Library

Assessment Clinical Trial Eligibility Overview. Trial Name: NCT05835154 — N/A

Sarcoma Research Study Groups: Supportive Care (advanced care planning checklist)

Sarcoma Clinical Trial 2023: Assessment Highlights & Side Effects. Trial Name: NCT05835154 — N/A

Assessment 2023 Treatment Timeline for Medical Study. Trial Name: NCT05835154 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there any availability in this trial for potential participants?

"According to clinicaltrials.gov, the recruitment process for this medical trial has since ended after being initially posted on June 1st 2023 and receiving its last update on April 27th 2023. While no longer recruiting participants, there are currently 447 other studies actively seeking candidates."

Answered by AI

What results are researchers expecting to observe with this medical study?

"The primary purpose of this clinical trial, which is to be evaluated over a set period of time at enrolment, is determining the feasibility as measured by how many volunteers complete the intervention. Secondary outcomes include evaluating changes in functional status with PROMIS Cancer Function Brief (a 12-item scale scored on a 5-point Likert), patients' engagement in clinical conversations with specialist providers through four yes/no questions and discussion of advance directives using an 8-item measure involving family and doctor interactions."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma

2024. "A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05835154.

All > Sarcoma